Claflin Bruce L. 4
4 · IDEXX LABORATORIES INC /DE · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
IDEXX (IDXX) Director Bruce Claflin Receives Option Grant & DSUs
What Happened Bruce L. Claflin, a director of IDEXX Laboratories (IDXX), received two equity awards on 2026-05-12: a 525-share option grant (derivative) and 234 deferred stock units (DSUs). Both awards show a $0.00 acquisition price in the Form 4 (no cash paid). These are grants (not open-market purchases or sales) and are typical director compensation rather than immediate purchases or dispositions.
Key Details
- Transaction date: 2026-05-12; Form 4 filed 2026-05-14 (timely filing within the standard reporting window).
- Award amounts and price: 525 shares (option) @ $0.00; 234 DSUs @ $0.00.
- Shares owned after transaction: not specified in the filing.
- Vesting/terms (from footnotes):
- Option (525): vests in one installment on the one-year anniversary of the grant or on the date of the 2027 annual meeting of shareholders, whichever is earlier.
- DSUs (234): each unit converts to one share when payable; vests on the same schedule and, by default, is payable as common stock shortly after the director’s resignation from the board.
- Transaction type: Grants/Awards (code A on the Form 4).
Context These awards are compensatory grants to a non-employee director and do not represent a market purchase or sale. Options and DSUs typically vest over time and only convert to transferable shares under the stated conditions, so they do not indicate an immediate change in market exposure by the insider.
Insider Transaction Report
- Award
Non-Qualified Stock Option (right-to-buy)
[F1]2026-05-12+525→ 525 totalExercise: $533.92Exp: 2036-05-11→ Common Stock (525 underlying) - Award
Deferred Stock Unit
[F2]2026-05-12+234→ 1,354 total→ Common Stock (234 underlying)
Footnotes (2)
- [F1]Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
- [F2]Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.